Lyska L. Emerson, M.D.
Lyska L. Emerson, M.D.
- Anatomic Pathology Resident Education Coordinator
- Medical Director, Huntsman Cancer Hospital Pathology Gross Dissection Laboratory
About Lyska L. Emerson, M.D.
Lyska L. Emerson, M.D., is an associate professor (clinical tract), in the Division of Anatomic Pathology at the University of Utah School of Medicine. She is a surgical pathologist who serves the pathology needs of the University Hospital, the Huntsman Cancer Hospital, and ARUP Laboratories. Dr. Emerson's subspecialty interest and service work is predominantly in gastrointestinal pathology although she also practices general surgical pathology. She currently collaborates on several translational research projects with colleagues at the University Hospital and Huntsman Cancer Institute.
Dr. Emerson supports the Huntsman Cancer Hospital specialty tumor boards. These specialty conferences involve a multidisciplinary team approach which includes surgeons, oncologists, radiologists, radiation oncologists and pathologists. Dr. Emerson is currently the pathologist for the Thoracic Multidisciplinary Group.
Dr. Emerson is involved in the pathology residency training program as coordinator of resident AP education. Teaching and mentoring both residents and medical students is a significant component of Dr. Emerson's teaching commitment.
Dr. Emerson received her baccalaureate degree from Baylor University in Waco, Texas. She received her medical degree from the University of Texas-Houston Health Sciences Center and then went on to train in combined anatomic and clinical pathology residency programs at the University of New Mexico in Albuquerque, NM and the University of Texas-Houston Health Sciences Center in Houston, Texas. Prior to joining the faculty at the University of Utah, she completed a fellowship in surgical pathology at the University of Utah Health Sciences Center in Salt Lake City, Utah.
- Wu X., E.K. Jeong, L. Emerson, J. Hoffman, D.L. Parker, and Z.R. Lu. Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers. Mol Pharm 2010 Feb 1; 7 (1): 41-8
- Peterson, K.A., K.L. Thomas, K. Hilden, L.L. Emerson, J.C. Wills, and J.C. Fang. Comparison of esomeprazole and aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2010 55: 1313-1319. Epub 2009 June 18.
- Wallander, M., E.A. Jarboe, L.L. Emerson, T. Liu, H. Thaker, J.A. Holden, S. Tripp, and L.J. Layfield. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts. Appl Immunohistochem Mol Morphol 2010 May; 18 (3): 231-5. Epub 2009 Dec 29.
- Alkhatib, A.A., R. Craig, A.K. Tuteja, and L.L. Emerson. Progression of solitary rectal ulcer over a two year period. Gastrointest Endosc Epub 2010 Jun 9.
- Scaife, C.L. J. Shea, L. Emerson, K. Boucher, M.A. Firpo, M.C. Beckerle, and S.J. Mulvihill. Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma, HPB (Oxford) 2010 Jun; 12 (5): 352-8.
- Poruk, K.E., M.A. Firpo, L.M. Huerter, C.L. Scaife, L.L. Emerson, K.M. Boucher, K.A. Jones, S.J. Mulvihill. Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2010 Oct: 19(10): 2605-10. Epub 2010 Aug 20. PMCID: PMC2952057.
- Goldfarb-Rumyantzev, A., S. Wright, R. Ragasa, D. Ostler, J. Van Orden, L. Smith, E. Efimova, L. Emerson, S.S. Gurpratapp, and F. Shihab. Factors associated with medication non-adherence in kidney transplant recipients. Nephron Clin Pract 2011; 117: 33-39.
- Wallander, M.L., L.L. Emerson, S. Tripp, D. Davis, N. Mamalis, J.A. Holden, and L.J. Layfield. KIT and PDGFRA Mutations in Ocular Melanoma: Frequency and Anatomic Distribution. Mod Path 2011 Aug; 24(8): 1031-5.
- Scwartz, JJ, AK Phan, E Hillas, J Sorensen, M Firpo, H Thiesset, R Kim, JB Sorensen, T Box, WR Hutson, T Kennedy, L Emerson. Amelioration of Hepatic Inflammation in a Mouse Model of NASH Using a Dithiocarbamate Derivative, submitted.
- Poruk, K.E., Firpo, M.A., Scaife, C.L., Adler, D.G., Emerson, L.L., Boucher, K.M., and S.J. Mulvihill. Serum Osteopontin and TIMP-1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma. Pancreas, submitted.
- All Publications: Click Here
- 2000-2001, Surgical Pathology Fellowship, University of Utah Health Sciences Center, Salt Lake City, Utah
- 1997-2000, Anatomic and Clinical Pathology Residency, University of Texas-Houston Health Sciences Center, Houston, Texas
- 1995-1997, Anatomic and Clinical Pathology Residency, University of New Mexico Health Sciences Center, Albuquerque, New Mexico
- 1995, M.D. University of Texas Health Sciences Center at Houston, Houston, Texas
- 1990, B.S. in Biology, Baylor University, Waco, Texas